Baxter International Inc Quick Ratio (BAX) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Baxter International Inc   (NYSE: BAX)

Baxter International Inc 's Quick Ratio

BAX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0.52 below Baxter International Inc average.

Within Medical Equipment & Supplies industry 147 other companies have achieved higher Quick Ratio than Baxter International Inc in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 2591, from total ranking in the second quarter 2026 at 2943.

Explain Quick Ratio?
How much Cash & cash equivalents BAX´s has?
What are BAX´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BAX/financial-strength
https://api.csimarket.com/api/v1/companies/BAX/fundamentals
https://api.csimarket.com/api/v1/companies/BAX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
BAX Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 0.9 %
Y / Y Cash & cash equivalent Change 14.48 %
Quick Ratio MRQ 0.52
BAX's Total Ranking # 2591
Seq. Current Liabilities Change 6.07 %
Seq. Cash & cash equivalent Change -8.14 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 148
Healthcare Sector # 738
Overall Market # 2594


Quick Ratio Statistics
High Average Low
1.49 0.66 0.2
(Jun 30 2017)   (Dec. 29. 2005)




Financial Statements
Baxter International Inc 's Current Liabilities $ 3,809 Millions Visit BAX's Balance sheet
Baxter International Inc 's Cash & cash equivalent $ 1,976 Millions Visit BAX's Balance sheet
Source of BAX's Sales Visit BAX's Sales by Geography


Cumulative Baxter International Inc 's Quick Ratio

BAX's Quick Ratio for the trailling 12 Months

BAX Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -15.82 %
Y / Y Cash & cash equivalent TTM Growth 8.57 %
Quick Ratio TTM 0.58
Total Ranking TTM # 1890
Seq. Current Liabilities TTM Growth 0.24 %
Seq. Cash & cash equivalent TTM Growth 3.18 %


On the trailing twelve months basis BAX Cash & cash equivalent increased by 14.48 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Baxter International Inc 's Quick Ratio to 0.58, Quick Ratio remained below BAX average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Baxter International Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending second quarter 2026 at 4036.

Explain Quick Ratio?
How much Cash & cash equivalents BAX´s has?
What are BAX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 902
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
1.3 0.67 0.29
(Dec 31 2017)   (Dec. 29. 2005)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Envista Holdings Corporation  1.42 $ 1,158.800  Millions$ 816.300  Millions
Inogen Inc   1.38 $ 96.840  Millions$ 70.265  Millions
Intelligent Bio Solutions Inc   1.30 $ 5.930  Millions$ 4.578  Millions
Si bone inc   1.20 $ 35.460  Millions$ 29.619  Millions
Medline Inc   1.12 $ 3,608.000  Millions$ 3,211.000  Millions
Pro dex Inc   1.10 $ 14.219  Millions$ 12.884  Millions
Penumbra Inc  1.09 $ 254.282  Millions$ 233.810  Millions
Koru Medical Systems Inc   1.08 $ 7.364  Millions$ 6.792  Millions
Establishment Labs Holdings Inc   1.06 $ 75.812  Millions$ 71.611  Millions
Globus Medical Inc   1.02 $ 517.435  Millions$ 507.938  Millions
Envoy Medical Inc   0.98 $ 14.570  Millions$ 14.861  Millions
Integra Lifesciences Holdings Corp  0.95 $ 311.930  Millions$ 329.002  Millions
Myomo Inc   0.93 $ 11.946  Millions$ 12.902  Millions
Strata Critical Medical Inc   0.92 $ 41.641  Millions$ 45.118  Millions
Haemonetics Corporation  0.87 $ 260.712  Millions$ 300.838  Millions
Treace Medical Concepts Inc   0.86 $ 39.798  Millions$ 46.079  Millions
Innovage Holding Corp   0.85 $ 162.993  Millions$ 192.479  Millions
Lifestance Health Group Inc   0.84 $ 218.818  Millions$ 261.129  Millions
Neuronetics Inc   0.82 $ 22.106  Millions$ 26.856  Millions
Orthopediatrics Corp  0.80 $ 44.229  Millions$ 55.632  Millions
Livanova Plc  0.76 $ 563.467  Millions$ 740.193  Millions
West Pharmaceutical Services Inc   0.72 $ 464.100  Millions$ 644.300  Millions
Resmed Inc   0.72 $ 1,010.742  Millions$ 1,406.488  Millions
Electrocore Inc   0.69 $ 7.506  Millions$ 10.866  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.69 $ 8.124  Millions$ 11.778  Millions
Sintx Technologies Inc   0.67 $ 2.005  Millions$ 3.004  Millions
Privia Health Group Inc   0.66 $ 446.283  Millions$ 674.358  Millions
Lensar Inc   0.64 $ 12.622  Millions$ 19.811  Millions
Orthofix Medical Inc   0.62 $ 86.322  Millions$ 138.385  Millions
Carlisle Companies Incorporated  0.62 $ 546.700  Millions$ 880.300  Millions

Date modified: 2026-10-30T16:58:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.